First author | Year | Study design | Total patients includeda | PROM(s) | Change score(s) | Method of calculation | Follow-up (year) |
---|---|---|---|---|---|---|---|
Berliner [11] | 2017 | 3 | 562 | KOOS, SF-12 | MCID | Distribution | 1 |
Blevins [12] | 2019 | 3 | 228 | KOOS, SF-12 | MCID | Distribution | 2 |
Busija [13] | 2008 | 4 | 379 (105) | SF-36 | MDC | Distribution | 0.5, 1; 5 |
Chesworth [5] | 2008 | 2 | 3,657 (1,578) | WOMAC | CID | Anchor | 1 |
Clement [14] | 2013 | 2 | 505 | OKS, SF-12 | MCID | Anchor | 1 |
Clement [15] | 2018 | 3 | 2,589 | WOMAC | MCID, MDC, MIC | Bothb | 1 |
Clement [16] | 2019 | 3 | 2,589 | SF-12 | MCID, MDC, MIC | Bothb | 1 |
Connelly [17] | 2019 | 3 | 383; 301 | KOOS, EQ-5D/VAS, NRS | PASS | Anchor | 1; 3 |
Fontana [18] | 2019 | 3 | 13,719 (6,480) | SF-36 | MCID | Distribution | 2 |
Goodman [19] | 2020 | 3 | 10,622 (4,641) | KOOS | MCID | Anchor | 2 |
Harris [20] | 2021 | 2 | 637 | KOOS | MCID | Anchor | 1 |
Kagan [21] | 2018 | 2 | 91 | PROMIS | MCID | Distribution | 0.13; 0.25; 0.5; 1 |
Kuo [22] | 2020 | 2 | 1,088 (587) | KOOS | MCID | Both | 1 |
Lawrie [23] | 2020 | 3 | 172 | PROMIS | MCID | Distribution | 1 |
Lyman [24] | 2018 | 3 | 4,953 (2,630) | KOOS | MCID, MDC, SCB | Bothc | 2 |
Maxwell [25] | 2013 | 2 | 271 | WOMAC | PASS | Anchor | 2.5; 5 |
Razak [26] | 2016 | 3 | 3,328 | OKS, SF-36 | MCID | Distribution | 5 |
Sayers [6] | 2017 | 2 | 400 (190) | ICOAP | MCID, MID | Bothd | 0.25; 0.5; 1 |